356 related articles for article (PubMed ID: 28084058)
1. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
[TBL] [Abstract][Full Text] [Related]
2. Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
Takei K; Nakagawa Y; Wang Y; Han SI; Satoh A; Sekiya M; Matsuzaka T; Shimano H
J Pharmacol Sci; 2017 Apr; 133(4):214-222. PubMed ID: 28366492
[TBL] [Abstract][Full Text] [Related]
3. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.
Raza-Iqbal S; Tanaka T; Anai M; Inagaki T; Matsumura Y; Ikeda K; Taguchi A; Gonzalez FJ; Sakai J; Kodama T
J Atheroscler Thromb; 2015 Aug; 22(8):754-72. PubMed ID: 26040752
[TBL] [Abstract][Full Text] [Related]
7. Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643.
Li G; Brocker CN; Xie C; Yan T; Noguchi A; Krausz KW; Xiang R; Gonzalez FJ
J Gastroenterol Hepatol; 2018 May; 33(5):1138-1145. PubMed ID: 29141109
[TBL] [Abstract][Full Text] [Related]
8. Selective peroxisome proliferator-activated receptor-α modulator K-877 regulates the expression of ATP-binding cassette transporter A1 in pancreatic beta cells.
Dong T; Lyu J; Imachi H; Kobayashi T; Fukunaga K; Sato S; Ibata T; Yoshimoto T; Yonezaki K; Iwama H; Zhang G; Murao K
Eur J Pharmacol; 2018 Nov; 838():78-84. PubMed ID: 30201376
[TBL] [Abstract][Full Text] [Related]
9. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
11. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
[TBL] [Abstract][Full Text] [Related]
12. Discovery of peroxisome proliferator-activated receptor α (PPARα) activators with a ligand-screening system using a human PPARα-expressing cell line.
Tachibana K; Yuzuriha T; Tabata R; Fukuda S; Maegawa T; Takahashi R; Tanimoto K; Tsujino H; Nunomura K; Lin B; Matsuura Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Kobayashi T; Ishimoto K; Miyachi H; Doi T
J Biol Chem; 2018 Jun; 293(26):10333-10343. PubMed ID: 29764933
[TBL] [Abstract][Full Text] [Related]
13. The PPARα agonist fenofibrate suppresses B-cell lymphoma in mice by modulating lipid metabolism.
Huang J; Das SK; Jha P; Al Zoughbi W; Schauer S; Claudel T; Sexl V; Vesely P; Birner-Gruenberger R; Kratky D; Trauner M; Hoefler G
Biochim Biophys Acta; 2013 Oct; 1831(10):1555-65. PubMed ID: 23628473
[TBL] [Abstract][Full Text] [Related]
14. Selective peroxisome proliferator-activated receptor α modulators (SPPARMα): the next generation of peroxisome proliferator-activated receptor α-agonists.
Fruchart JC
Cardiovasc Diabetol; 2013 May; 12():82. PubMed ID: 23721199
[TBL] [Abstract][Full Text] [Related]
15. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α.
Cui S; Pan XJ; Ge CL; Guo YT; Zhang PF; Yan TT; Zhou JY; He QX; Cheng LH; Wang GJ; Hao HP; Wang H
Chin J Nat Med; 2021 Jun; 19(6):401-411. PubMed ID: 34092291
[TBL] [Abstract][Full Text] [Related]
16. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
[TBL] [Abstract][Full Text] [Related]
17. Effect of pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor α modular (SPPARMα), in atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury.
Konishi H; Miyauchi K; Onishi A; Suzuki S; Fuchimoto D; Shitara J; Endo H; Wada H; Doi S; Naito R; Ogita M; Dohi T; Kasai T; Daida H
PLoS One; 2020; 15(11):e0241195. PubMed ID: 33201888
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.
Maki T; Maeda Y; Sonoda N; Makimura H; Kimura S; Maeno S; Takayanagi R; Inoguchi T
Metabolism; 2017 Jun; 71():33-45. PubMed ID: 28521876
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.
Kong L; Ren W; Li W; Zhao S; Mi H; Wang R; Zhang Y; Wu W; Nan Y; Yu J
Lipids Health Dis; 2011 Dec; 10():246. PubMed ID: 22208561
[TBL] [Abstract][Full Text] [Related]
20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]